NHS-sourced information. General health information only — not personal medical advice. Always consult your GP or specialist.

Home Health News Cancer
NICE Cancer 17 March 2026

Nivolumab with chemotherapy for untreated unresectable or metastatic urothelial cancer (terminated appraisal)

TA1141

📋 What this means for you AI-generated plain English summary
# Nivolumab with Chemotherapy for Advanced Bladder Cancer
What this means for you:** Doctors can now use a combination treatment of nivolumab (a cancer-fighting drug) plus chemotherapy for patients with advanced bladder cancer that cannot be surgically removed or has spread to other parts of the body, and this combination has been approved as an effective option.
What you should do:** If you have been diagnosed with advanced bladder cancer and your doctor recommends this treatment, ask them whether nivolumab combined with chemotherapy might be right for youβ€”this approval means it's now a recognized treatment option available to discuss with your medical team.
Key takeaway:** This approval gives patients with serious, spreading bladder cancer access to a newer treatment approach that combines an immunotherapy drug with traditional chemotherapy, offering another fighting option against this type of cancer.

Always speak to your doctor before making any changes to your health or treatment.

New Guidance: NICE
View official guidance ↗

TA1141

📋 What this means for you: Speak to your GP or specialist to understand how this guidance affects your care.
Read full article on NICE ↗

This article summarises content originally published by NICE. PatientIQ provides independent plain English summaries.

More Cancer News

Free health updates

Stay one step ahead
of your condition.

New trial alerts, treatment news, and plain-English updates β€” matched to your condition. Free forever.

No spam. Unsubscribe anytime. Your data is private.